Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Article Page

Abstract

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Keywords: connective tissue diseases, cyclophosphamide, interstitial lung diseases, mycophenolate, nintedanib, pierfenidone, rituximab.

Citation: Erre GL, Mangoni AA. Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue. Drugs in Context 2021; 10: 2020-12-1. DOI: 10.7573/dic.2020-12-1

Contributions: EGL and AMM conceived the Editorial, drafted and revised the paper. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2020/12/dic.2020-12-1-COI.pdf

Acknowledgements: None.

Funding declaration: There was no funding associated with the preparation of this article.

Copyright: Copyright © 2021 Erre GL, Mangoni AA. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Correct attribution: Copyright © 2021 Erre GL, Mangoni AA. https://doi.org/10.7573/dic.2020-12-1. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0.

Article URL: https://www.drugsincontext.com/current-therapeutic-strategies-in-connective-tissue-disease-related-interstitial-lung-disease:-introduction-to-the-special-issue

Correspondence: Gian Luca Erre, Dipartimento di Scienze Mediche, Chirurgiche e sperimentali, Università degli Studi di Sassari, Dipartimento di Specialità Mediche, Azienda Ospedaliero-Universitaria di Sassari, 07100 Sassari, Italy. glerre@uniss.it

Provenance: Invited; externally peer reviewed.

Submitted: 2 December 2020; Accepted: 4 December 2020; Publication date: 15 January 2021.

Drugs in Context is published by BioExcel Publishing Ltd. Registered office: Plaza Building, Lee High Road, London, England, SE13 5PT.

BioExcel Publishing Limited is registered in England Number 10038393. VAT GB 252 7720 07.

For all manuscript and submissions enquiries, contact the Editorial office editorial@drugsincontext.com

For all permissions, rights and reprints, contact David Hughes david.hughes@bioexcelpublishing.com

Download free full text PDF